Medication info
Moxiklan Tablet 375 mg (Amoxicillin-Potassium Clavulanate)

Moxiklan Tablet 375 mg (Amoxicillin-Potassium Clavulanate)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›250mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
This is a white or almost white oval film-coated tablet.
Packaging
100 tablets (10 tablets/PTPX10)
Approval status
Active

MFDS item code 201801322 · Approved 2018.03.26 · Insurance code 622803140

Summary

Main use
Treatment of respiratory tract, genitourinary, skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this drug should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. - Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is required in patients with creatinine clearance (CrCl) of 30 mL/min or higher. 10 ~ 30 mL/min Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanate decrease.)
Child dose
Pediatric patients aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory tract, genitourinary, skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchial pneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medication is used to treat various infections effectively by acting against different bacteria. It improves respiratory infections such as acute and chronic bronchitis, lobar and bronchial pneumonia, tonsillitis, sinusitis, and otitis media. It is also effective in treating urinary tract infections like cystitis, urethritis, pyelonephritis, as well as pelvic infections and sexually transmitted diseases like gonorrhea. Additionally, it treats skin and soft tissue infections such as abscesses, cellulitis, wound infections, and osteomyelitis. It is widely used for the treatment of dental infections and is effective in treating various infection sites. This drug exhibits excellent efficacy in infection treatment, aiding patients in their recovery.

How to take

Adult dose

The dose of this drug should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. - Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is required in patients with creatinine clearance (CrCl) of 30 mL/min or higher. 10 ~ 30 mL/min Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanate decrease.)

Child dose

Pediatric patients aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.

Precautions

This medication is a penicillin antibiotic and should not be used in certain patients. First, patients with a history of allergy to this drug, its ingredients, or beta-lactam antibiotics may experience severe allergic reactions and should not take it. Additionally, patients with viral infections such as infectious mononucleosis or lymphocytic leukemia are at a higher risk of skin rashes while taking this medication, so it is advisable to avoid it. Patients with previous liver problems due to this medication or penicillin group drugs also pose a risk of recurrence and should refrain from taking it. Patients with impaired liver function should use this drug cautiously as it may further worsen liver function. Patients with moderate to severe renal impairment should adjust dosing intervals, as prolonged drug retention in the body may increase the risk of side effects. Patients with a history of allergies or family history, individuals who have difficulty with oral intake, the elderly, and patients in poor general condition should be cautious while taking this drug due to the risk of bleeding from vitamin K deficiency. Patients with gastrointestinal diseases or severe vomiting or diarrhea may not absorb the medication well, which necessitates caution. This drug may cause various side effects in the gastrointestinal system, with diarrhea, vomiting, abdominal pain, and appetite loss being common. Although rare, serious intestinal disorders such as pseudomembranous colitis may occur, so if diarrhea worsens or abdominal pain becomes severe, immediate discontinuation of the drug and consultation with a physician is recommended. Liver function abnormalities can also occur, with elevated liver enzymes or symptoms of jaundice, so liver function tests are necessary intermittently during treatment. Skin-related side effects such as itching or rashes, and in severe cases, serious skin reactions like Stevens-Johnson syndrome may develop, so if any unusual symptoms appear, immediate discontinuation is necessary. Blood-related side effects such as leukopenia, anemia, and thrombocytopenia have been reported rarely, making regular blood tests important. Since it may affect the central nervous system, dizziness, insomnia, seizures, etc. may occur rarely, and if any unusual symptoms arise, patients should inform their physician. It may also affect the kidneys, and symptoms such as acute renal failure or hematuria may appear, so kidney function should be monitored periodically. While taking this drug, there is a risk of fungal infections like candidiasis due to the disruption of the intestinal bacterial balance, necessitating caution. Symptoms of bleeding tendencies due to vitamin K deficiency or symptoms of vitamin B deficiencies may also occur, and conditions should be monitored. To prevent the development of resistant bacteria, it is advisable to administer this drug only for the necessary period following susceptibility testing. Patients with a history of hypersensitivity to penicillin drugs are at risk of severe allergic reactions like anaphylaxis, so an allergy history must be consulted before administration. Anaphylactic shock may occur, therefore, patients must be monitored closely after administration to ensure their stability. While using antibiotics, there is a risk of pseudomembranous colitis, so if diarrhea or abdominal cramps become severe, immediate discontinuation of the drug and consultation with a physician is essential. Long-term use may lead to proliferation of non-susceptible bacteria, thus careful monitoring is required when administered for over 14 days. Symptoms of liver dysfunction may manifest, and regular liver function tests should be conducted, especially with prolonged use beyond 14 days. As this medication is excreted through the kidneys, dose adjustments are necessary for patients with decreased renal function. Patients suspected of having infectious mononucleosis should avoid using this medication. If skin rashes or serum sickness symptoms occur, drug administration must be discontinued immediately, following the physician's instructions. In cases of long-term administration, regular examinations of kidney, liver, and hematopoietic functions should be conducted, and any abnormal signs should prompt immediate action. This drug may interact with other medications; caution is required when used in combination, particularly with anticoagulants, anti-inflammatory drugs, and certain antibiotics, and consultation with a specialist is necessary. Women who are pregnant or may become pregnant should avoid taking this medication during the first three months as a precaution, and nursing women should also be cautious as side effects may occur in the baby. It is not recommended for children under 12 years of age or those weighing less than 40 kg. Elderly patients should use this drug cautiously as they may have a higher risk of side effects due to declining physical function; hence, dosages and intervals should be carefully adjusted. This medication can affect the results of certain clinical tests, such as urine sugar tests, so these factors should be considered during evaluation. In case of overdose, gastrointestinal symptoms and renal failure, seizures, etc. may occur, so immediate cessation and suitable treatment must be provided.

Side effects

  • Diarrhea
  • pseudomembranous colitis
  • dyspepsia
  • stomatitis
  • gastritis
  • glossitis
  • black hairy tongue
  • nausea
  • vomiting
  • loss of appetite
Show 75 more
  • abdominal pain
  • abdominal bloating
  • constipation
  • colonic pain
  • acid reflux
  • loose stools
  • dry mouth
  • acute pancreatitis
  • candidiasis
  • antibiotic-induced colitis
  • bloody stools
  • itching
  • erythema multiforme
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • vesicular exfoliative dermatitis
  • acute generalized pustular psoriasis
  • angioedema
  • anaphylaxis
  • serum sickness syndrome
  • hypersensitivity vasculitis
  • bronchospasm
  • dyspnea
  • laryngeal edema
  • anaphylactic shock
  • reversible leukopenia
  • reversible thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • prolonged prothrombin time
  • vaginal itching
  • burning sensation
  • increased secretion
  • restlessness
  • anxiety
  • behavioral changes
  • confusion
  • drowsiness
  • insomnia
  • hyperactivity
  • dizziness
  • headache
  • convulsions
  • antispasmodics
  • fever
  • altered consciousness
  • aseptic meningitis
  • acute renal failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • vitamin K deficiency symptoms
  • vitamin B complex deficiency symptoms
  • linear IgA disease
  • dysgeusia
  • malaise
  • dermatitis
  • oral edema
  • gastric pain
  • fluid and electrolyte imbalance
  • rash
  • hyperactivity
  • drowsiness
  • decreased urine output
  • renal failure
  • interstitial cerebral convulsions
  • hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a closed container to prevent moisture and kept in a cool temperature between 1 to 25 degrees Celsius. Storing it this way will help maintain the drug's effectiveness for longer.

Appearance and packaging

Appearance

This is a white or almost white oval film-coated tablet.

Package unit

100 tablets (10 tablets/PTPX10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.